Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral lipoic acid for diabetic small fiber neuropathy and diabetic corneal neuropathy
ChiCTR1900025489Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of alpha-lipoic acid in small fiber neuropathy (SFN) and diabetic corneal neuropathy (DCN) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: TSS score, MNSI score and 1 more. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
alpha-lipoic acid
03
Conditions
small fiber neuropathy (SFN)diabetic corneal neuropathy (DCN)
Beyond the preview
Go deeper on ChiCTR1900025489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025489.